 BOSTON LAUSANNE, Switzerland-- BUSINESS WIRE --SOPHiA GENETICS SA NASDAQ: SOPH today announced that Dr. Jurgi Camblong, Chief Executive Officer and Co-Founder, is scheduled to present at the J.P. Morgan 2023 Healthcare Conference on Tuesday, January 10, 2023, at 8:15 a.m. PST in San Francisco. 